drugset / Trial / NCT01535677

To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately

NCT01535677

Phase 1 Completed 71 enrolled AstraZeneca Bristol-Myers Squibb · collab
RandomizedCrossoverOpen-labelBasic science

Summary

This is an open-label, randomised study to compare the similarity of a combination Dapagliflozin/Metformin tablet with the two drugs administered separately under fasting and fed conditions in healthy volunteers.

Timeline

Start
2013-04
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 5 mg Oral
Subject Dapagliflozin Small molecule 850 mg Oral
Subject Metformin Small molecule 850 mg Oral